Heilongjiang ZBD Pharmaceutical Co., Ltd. (SHA:603567)
China · Delayed Price · Currency is CNY 6.38
-0.50 (-7.27%)
Jul 29, 2026, 3:00 PM CST
SHA:603567 Balance Sheet
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Assets
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 54.13 | 78.91 | 1,053 | 1,454 | 1,001 | 1,551 |
Short-Term Investments | 4.47 | 4.74 | 15.39 | 14.74 | 59.45 | 13.63 |
Trading Asset Securities | 0.41 | 0.44 | 0.54 | 0.43 | 0.51 | - |
Cash & Short-Term Investments | 59 | 84.09 | 1,069 | 1,469 | 1,061 | 1,565 |
Cash Growth | -92.55% | -92.14% | -27.22% | 38.43% | -32.17% | 1.68% |
Accounts Receivable | 2,414 | 2,570 | 3,156 | 2,525 | 3,041 | 3,369 |
Other Receivables | 665.52 | 672.65 | 1,085 | 1,955 | 811.14 | 796.85 |
Receivables | 3,080 | 3,242 | 4,242 | 4,480 | 3,852 | 4,166 |
Inventory | 1,293 | 1,318 | 1,488 | 720.89 | 1,006 | 733.26 |
Prepaid Expenses | - | - | - | 19.72 | 67.58 | 56.75 |
Other Current Assets | 606.43 | 504.02 | 394.08 | 478.08 | 394.31 | 155.07 |
Total Current Assets | 5,038 | 5,149 | 7,193 | 7,168 | 6,381 | 6,676 |
Property, Plant & Equipment | 1,388 | 1,419 | 1,481 | 1,426 | 1,468 | 1,455 |
Long-Term Investments | 1,287 | 1,311 | 1,298 | 1,266 | 1,223 | 1,236 |
Goodwill | 14.82 | 14.82 | 14.82 | 14.82 | 17.22 | 18.5 |
Other Intangible Assets | 1,054 | 1,060 | 980.37 | 784.03 | 764.29 | 209.36 |
Long-Term Deferred Tax Assets | 660.56 | 615.24 | 321.12 | 302.6 | 242.28 | 159.23 |
Long-Term Deferred Charges | 211.33 | 214.85 | 246.06 | 223.03 | 217.62 | 167.05 |
Other Long-Term Assets | 845.11 | 851.5 | 1,178 | 1,282 | 1,364 | 1,585 |
Total Assets | 10,500 | 10,634 | 12,713 | 12,466 | 11,678 | 11,506 |
Liabilities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Accounts Payable | 363.28 | 341.1 | 278.16 | 332.99 | 806.25 | 797 |
Accrued Expenses | 56.33 | 59.78 | 50.88 | 43.92 | 35.76 | 34.99 |
Short-Term Debt | 1,527 | 1,311 | 1,296 | 876.19 | 1,302 | 600.76 |
Current Portion of Long-Term Debt | 1,109 | 1,748 | 439.61 | 972.69 | 1,142 | 1,047 |
Current Portion of Leases | - | 5.63 | 4.55 | 3.8 | 12.46 | 3.23 |
Current Income Taxes Payable | 134.73 | 121.77 | 114.16 | 101.9 | 190.13 | 56.84 |
Current Unearned Revenue | 95.66 | 138.2 | 55.3 | 36.46 | 54.97 | 12.98 |
Other Current Liabilities | 352.99 | 359.58 | 281.61 | 387.2 | 323.34 | 259.28 |
Total Current Liabilities | 3,639 | 4,086 | 2,520 | 2,755 | 3,867 | 2,812 |
Long-Term Debt | 506 | 47 | 1,546 | 1,298 | 460 | 1,290 |
Long-Term Leases | 5.34 | 6.2 | 7.97 | 0.14 | 9.96 | 3.53 |
Long-Term Unearned Revenue | 132.68 | 137.45 | 150.11 | 169.34 | 181.88 | 197.24 |
Long-Term Deferred Tax Liabilities | 20.48 | 20.81 | 37.91 | 26.02 | 5.91 | 1.37 |
Other Long-Term Liabilities | 58.11 | 58.11 | 159.3 | 176.57 | 46.37 | 150.42 |
Total Liabilities | 4,362 | 4,355 | 4,422 | 4,425 | 4,571 | 4,455 |
Shareholders' Equity
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Common Stock | 941 | 941 | 941.14 | 941.96 | 941.96 | 941.96 |
Additional Paid-In Capital | 2,323 | 2,323 | 2,339 | 2,344 | 2,350 | 2,350 |
Retained Earnings | 2,843 | 3,023 | 4,531 | 4,281 | 3,834 | 3,749 |
Treasury Stock | -13.89 | -13.89 | -15.1 | -22.04 | -29.99 | - |
Comprehensive Income & Other | 8.29 | 7.78 | 4.99 | 3.93 | 3.2 | 2.75 |
Total Common Equity | 6,101 | 6,281 | 7,801 | 7,548 | 7,099 | 7,043 |
Minority Interest | 37.27 | -1.74 | 490.45 | 492.27 | 7.94 | 8.27 |
Shareholders' Equity | 6,139 | 6,279 | 8,291 | 8,041 | 7,107 | 7,051 |
Total Liabilities & Equity | 10,500 | 10,634 | 12,713 | 12,466 | 11,678 | 11,506 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Total Debt | 3,148 | 3,118 | 3,294 | 3,151 | 2,926 | 2,945 |
Net Cash (Debt) | -3,089 | -3,034 | -2,225 | -1,682 | -1,865 | -1,380 |
Net Cash Growth | - | - | - | - | - | - |
Net Cash Per Share | -3.29 | -3.23 | -2.37 | -1.79 | -1.98 | -1.60 |
Filing Date Shares Outstanding | 941.65 | 939.27 | 941.09 | 939.4 | 939.4 | 941.96 |
Total Common Shares Outstanding | 941.65 | 939.27 | 941.09 | 939.4 | 939.4 | 941.96 |
Working Capital | 1,399 | 1,063 | 4,673 | 4,413 | 2,515 | 3,864 |
Book Value Per Share | 6.48 | 6.69 | 8.29 | 8.04 | 7.56 | 7.48 |
Tangible Book Value | 5,032 | 5,206 | 6,805 | 6,750 | 6,317 | 6,815 |
Tangible Book Value Per Share | 5.34 | 5.54 | 7.23 | 7.18 | 6.72 | 7.23 |
Buildings | - | 1,464 | 1,404 | 1,228 | 1,232 | 1,276 |
Machinery | - | 1,259 | 1,270 | 1,191 | 1,139 | 1,118 |
Construction In Progress | - | 151.69 | 149.42 | 284.29 | 260.83 | 137.33 |